Tempest Therapeutics (TPST)
(Delayed Data from NSDQ)
$3.44 USD
-0.10 (-2.82%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $3.44 0.00 (0.00%) 6:00 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Tempest Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -29.49 | -35.71 | -28.30 | -36.41 | -44.57 |
Depreciation/Amortization & Depletion | 0.38 | 0.64 | 0.37 | 1.10 | 1.05 |
Net Change from Assets/Liabilities | -2.68 | 0.87 | -0.61 | 0.30 | -2.05 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 4.43 | 3.13 | 2.58 | 4.57 | 4.35 |
Net Cash From Operating Activities | -27.36 | -31.07 | -25.96 | -30.44 | -41.22 |
Property & Equipment | -0.17 | -0.56 | -0.14 | -0.03 | -0.40 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 4.39 |
Other Investing Activities | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.17 | -0.56 | -0.10 | -0.03 | 3.99 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 35.60 | 8.86 | 33.53 | 5.53 | 27.15 |
Issuance (Repayment) of Debt | 0.00 | -4.74 | 15.00 | -0.15 | -0.20 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 7.28 | 10.53 | 0.00 | 0.00 |
Net Cash from Financing Activities | 35.60 | 11.40 | 59.06 | 5.39 | 26.94 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.22 | 0.03 |
Net Change In Cash & Equivalents | 8.08 | -20.23 | 33.01 | -24.85 | -10.26 |
Cash at Beginning of Period | 31.60 | 51.83 | 18.82 | 63.51 | 73.77 |
Cash at End of Period | 39.67 | 31.60 | 51.83 | 38.66 | 63.51 |
Diluted Net EPS | -1.91 | -3.09 | -7.47 | -28.94 | -48.73 |
Fiscal Year End for Tempest Therapeutics, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -29.49 | -22.00 | -15.22 | -7.64 |
Depreciation/Amortization & Depletion | NA | 0.38 | 0.30 | 0.21 | 0.13 |
Net Change from Assets/Liabilities | NA | -2.68 | -2.33 | -1.51 | -1.72 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 4.43 | 2.86 | 1.83 | 0.93 |
Net Cash From Operating Activities | NA | -27.36 | -21.18 | -14.70 | -8.30 |
Property & Equipment | NA | -0.17 | -0.16 | -0.16 | -0.05 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.17 | -0.16 | -0.16 | -0.05 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 35.60 | 1.25 | 1.23 | 0.04 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 35.60 | 1.25 | 1.23 | 0.04 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 8.08 | -20.09 | -13.63 | -8.31 |
Cash at Beginning of Period | NA | 31.60 | 31.60 | 31.60 | 31.60 |
Cash at End of Period | NA | 39.67 | 11.51 | 17.97 | 23.29 |
Diluted Net EPS | NA | -0.34 | -0.48 | -0.54 | -0.55 |